AZATHIOPRINE SODIUM

AZATHIOPRINE SODIUM was reported 2536 times

AZATHIOPRINE SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA STAGE IV 3 0.4286
1 SYNOVIAL FLUID ANALYSIS 16 0.1839
2 OSTEOSARCOMA RECURRENT 8 0.1333
3 PULMONARY VASCULITIS 68 0.1264
4 TOTAL LUNG CAPACITY ABNORMAL 44 0.1131
5 CAPILLARITIS 31 0.1123
6 HODGKIN'S DISEASE STAGE II 2 0.0833
7 MITE ALLERGY 54 0.0824
8 SPIROMETRY ABNORMAL 46 0.0769
9 COLOPATHY 4 0.0741
10 HEPATIC ENZYME 11 0.0738
11 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 42 0.0573
12 ANTIPHOSPHOLIPID ANTIBODIES 11 0.0564
13 MYCOTIC ALLERGY 47 0.0550
14 ANOVULATORY CYCLE 11 0.0531
15 ONYCHOMADESIS 221 0.0526
16 RHEUMATIC FEVER 229 0.0513
17 ONYCHOMYCOSIS 219 0.0499
18 DUST ALLERGY 48 0.0489
19 FACET JOINT SYNDROME 156 0.0479
20 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 332 0.0463
21 FINGER DEFORMITY 221 0.0456
22 PERIUMBILICAL ABSCESS 3 0.0448
23 NEURITIS 69 0.0447
24 PRODUCT LABEL CONFUSION 245 0.0420
25 FLUCTUANCE 2 0.0408
26 PERIPHERAL VENOUS DISEASE 157 0.0384
27 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 74 0.0363
28 GRIP STRENGTH DECREASED 307 0.0348
29 DRAIN SITE COMPLICATION 3 0.0345
30 RED BLOOD CELL SEDIMENTATION RATE DECREASED 9 0.0345
31 CONJUNCTIVITIS ALLERGIC 51 0.0344
32 DUODENAL ULCER PERFORATION 253 0.0340
33 C-REACTIVE PROTEIN ABNORMAL 216 0.0336
34 HEPATOSPLENIC T-CELL LYMPHOMA 12 0.0323
35 ILEOCAECAL RESECTION 11 0.0320
36 HAND DEFORMITY 390 0.0297
37 EYELID HAEMATOMA 2 0.0294
38 HELICOBACTER INFECTION 295 0.0287
39 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 3 0.0286
40 ACQUIRED PORPHYRIA 2 0.0282
41 SWOLLEN JOINT COUNT 7 0.0280
42 FOLLICULITIS 291 0.0277
43 NAIL DISORDER 241 0.0275
44 TENOSYNOVITIS STENOSANS 15 0.0269
45 PEMPHIGUS 337 0.0269
46 ENDOCARDITIS NONINFECTIVE 4 0.0268
47 BREAST CANCER STAGE III 173 0.0267
48 SYNOVIAL DISORDER 12 0.0264
49 COELIAC DISEASE 256 0.0261
50 NEONATAL HYPONATRAEMIA 3 0.0246
51 RESPIRATORY SYMPTOM 67 0.0235
52 LUPUS VULGARIS 29 0.0230
53 BLEPHAROSPASM 144 0.0228
54 LYMPHOCYTE COUNT 2 0.0227
55 DEEP VEIN THROMBOSIS POSTOPERATIVE 45 0.0225
56 LIVE BIRTH 188 0.0225
57 CONGENITAL BLADDER ANOMALY 3 0.0222
58 RETINITIS 38 0.0220
59 BURSITIS 263 0.0217
60 MUSCLE INJURY 176 0.0212
61 HYPERCHOLESTEROLAEMIA 202 0.0209
62 GASTROINTESTINAL STOMA OUTPUT ABNORMAL 3 0.0207
63 BACK INJURY 221 0.0203
64 PERICARDITIS 338 0.0201
65 HEPATIC ENZYME DECREASED 9 0.0200
66 SYNOVITIS 359 0.0199
67 NAIL OPERATION 8 0.0193
68 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 12 0.0180
69 NORMOCHROMIC NORMOCYTIC ANAEMIA 53 0.0176
70 LIP DRY 159 0.0175
71 GRIP STRENGTH 4 0.0175
72 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 35 0.0169
73 GLOSSODYNIA 371 0.0166
74 WOUND INFECTION 180 0.0164
75 PROCTOCOLECTOMY 5 0.0164
76 DISLOCATION OF VERTEBRA 37 0.0162
77 FORCED EXPIRATORY VOLUME DECREASED 45 0.0159
78 ANASTOMOTIC HAEMORRHAGE 3 0.0158
79 ADVERSE REACTION 206 0.0155
80 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 7 0.0153
81 SWOLLEN JOINT COUNT INCREASED 46 0.0144
82 JOINT RANGE OF MOTION DECREASED 186 0.0139
83 BONE EROSION 49 0.0138
84 ALLERGY TO CHEMICALS 17 0.0136
85 PRODUCT INTOLERANCE 3 0.0135
86 PULMONARY ALVEOLAR HAEMORRHAGE 72 0.0128
87 PILONIDAL DISEASE 3 0.0125
88 EAR INFECTION VIRAL 2 0.0125
89 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 7 0.0125
90 CARCINOID TUMOUR PULMONARY 3 0.0124
91 PREGNANCY INDUCED HYPERTENSION 2 0.0124
92 INTESTINAL ANASTOMOSIS 8 0.0124
93 NEUROLOGICAL SYMPTOM 69 0.0121
94 ORAL LICHEN PLANUS 6 0.0120
95 POSTOPERATIVE ABSCESS 8 0.0119
96 WOUND 333 0.0119
97 CONTRAINDICATED PRODUCT ADMINISTERED 354 0.0117
98 WRIST DEFORMITY 7 0.0114
99 SMALL INTESTINAL STENOSIS 12 0.0113
100 LIVER FUNCTION TEST INCREASED 240 0.0112
101 FOETAL MACROSOMIA 3 0.0108
102 NORMAL NEWBORN 56 0.0103
103 BILE DUCT STENOSIS 12 0.0100
104 OBESITY 158 0.0099
105 SYSTEMIC LUPUS ERYTHEMATOSUS 347 0.0098
106 PORPHYRIA ACUTE 14 0.0098
107 C-REACTIVE PROTEIN 9 0.0097
108 METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE 2 0.0097
109 STOMA CLOSURE 3 0.0096
110 X-RAY ABNORMAL 17 0.0095
111 HEPATITIS 243 0.0095
112 FIBROMYALGIA 229 0.0094
113 SCLERITIS 15 0.0094
114 JOB DISSATISFACTION 6 0.0092
115 BLOOD IRON ABNORMAL 9 0.0092
116 RHEUMATOID FACTOR POSITIVE 53 0.0092
117 CONGENITAL ANOMALY 71 0.0092
118 INTESTINAL FIBROSIS 2 0.0091
119 C-REACTIVE PROTEIN INCREASED 321 0.0088
120 MUCOCUTANEOUS ULCERATION 2 0.0088
121 CONJUNCTIVITIS BACTERIAL 3 0.0088
122 SERONEGATIVE ARTHRITIS 10 0.0087
123 RHEUMATOID NODULE 24 0.0087
124 IRRITABLE BOWEL SYNDROME 186 0.0087
125 TYPE 2 DIABETES MELLITUS 290 0.0086
126 DRUG-INDUCED LIVER INJURY 270 0.0086
127 OVERLAP SYNDROME 6 0.0086
128 GASTROENTERITIS CLOSTRIDIAL 3 0.0085
129 HYPOCHOLESTEROLAEMIA 3 0.0085
130 CYTOMEGALOVIRUS ENTERITIS 3 0.0084
131 BILIARY DILATATION 12 0.0082
132 KAPOSI'S SARCOMA 4 0.0080
133 VASCULITIS 90 0.0077
134 ARTERIOSCLEROSIS CORONARY ARTERY 51 0.0077
135 LIVER INJURY 186 0.0076
136 TASTE DISORDER 153 0.0075
137 MAMMOPLASTY 6 0.0075
138 POST PROCEDURAL DISCHARGE 5 0.0074
139 PALPABLE PURPURA 2 0.0073
140 THERAPEUTIC PRODUCT EFFECT DECREASED 326 0.0073
141 FULL BLOOD COUNT ABNORMAL 76 0.0072
142 GAIT INABILITY 240 0.0072
143 TESTICULAR DISORDER 7 0.0070
144 ARTHROPATHY 386 0.0069
145 CHRONIC SPONTANEOUS URTICARIA 8 0.0069
146 BLOOD CHOLESTEROL INCREASED 316 0.0068
147 PSORIATIC ARTHROPATHY 275 0.0068
148 DRUG TOLERANCE DECREASED 19 0.0068
149 SPONDYLOARTHROPATHY 4 0.0067
150 PROCTITIS ULCERATIVE 4 0.0066
151 HEPATIC ENZYME INCREASED 451 0.0066
152 ASPARTATE AMINOTRANSFERASE ABNORMAL 10 0.0066
153 DRUG LEVEL BELOW THERAPEUTIC 36 0.0065
154 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 42 0.0065
155 OBSTRUCTIVE AIRWAYS DISORDER 69 0.0062
156 TENOSYNOVITIS 17 0.0062
157 INFLAMMATION 314 0.0061
158 ILEECTOMY 2 0.0059
159 IMPAIRED HEALING 195 0.0059
160 EYE INJURY 18 0.0059
161 CUSHINGOID 19 0.0059
162 CHOLANGITIS SCLEROSING 12 0.0058
163 ELBOW DEFORMITY 2 0.0058
164 FAECAL CALPROTECTIN INCREASED 18 0.0057
165 ALLERGY TO ANIMAL 6 0.0056
166 EPILEPSY 172 0.0056
167 INFUSION RELATED REACTION 372 0.0056
168 BRAIN MALFORMATION 2 0.0056
169 OSTEOARTHRITIS 235 0.0055
170 ANTINUCLEAR ANTIBODY POSITIVE 18 0.0055
171 ARTERIOSCLEROSIS 52 0.0055
172 NIGHT SWEATS 176 0.0055
173 NODULE 71 0.0054
174 PLEURITIC PAIN 15 0.0054
175 PULMONARY FIBROSIS 104 0.0054
176 CREPITATIONS 16 0.0054
177 ANISOCORIA 2 0.0053
178 LUNG DISORDER 255 0.0052
179 ILEOSTOMY 13 0.0051
180 INFUSION SITE BRUISING 11 0.0051
181 NASAL DISCHARGE DISCOLOURATION 7 0.0051
182 CAMPYLOBACTER GASTROENTERITIS 3 0.0051
183 PRINZMETAL ANGINA 5 0.0050
184 AUTOIMMUNE DISORDER 49 0.0050
185 JC VIRUS INFECTION 8 0.0050
186 WHEEZING 292 0.0049
187 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 3 0.0049
188 GRANULOMA SKIN 4 0.0049
189 DRUG INTOLERANCE 471 0.0049
190 INTENTIONAL PRODUCT USE ISSUE 427 0.0049
191 METASTASES TO SPLEEN 2 0.0048
192 FAECAL CALPROTECTIN ABNORMAL 2 0.0048
193 EXOSTOSIS 44 0.0048
194 DERMATOMYOSITIS 12 0.0047
195 UTERINE DISORDER 11 0.0047
196 MOBILITY DECREASED 337 0.0047
197 ANAL FISSURE 25 0.0047
198 FOOT DEFORMITY 51 0.0046
199 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 323 0.0045
200 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 77 0.0045
201 LUPUS-LIKE SYNDROME 41 0.0045
202 INTRA-ABDOMINAL FLUID COLLECTION 8 0.0045
203 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 6 0.0044
204 MEIBOMIAN GLAND DYSFUNCTION 2 0.0044
205 DRUG LEVEL ABOVE THERAPEUTIC 20 0.0044
206 INFUSION SITE REACTION 13 0.0043
207 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 10 0.0043
208 RED BLOOD CELL SEDIMENTATION RATE INCREASED 48 0.0043
209 EAR MALFORMATION 2 0.0043
210 SERUM SICKNESS 12 0.0043
211 RETINAL VEIN THROMBOSIS 3 0.0043
212 LOWER RESPIRATORY TRACT INFECTION 195 0.0043
213 INTESTINAL FISTULA 6 0.0043
214 NEONATAL RESPIRATORY DISTRESS 4 0.0042
215 DISSEMINATED ASPERGILLOSIS 2 0.0042
216 HEPATIC CIRRHOSIS 79 0.0042
217 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 6 0.0042
218 HODGKIN'S DISEASE 3 0.0041
219 NEUROENDOCRINE CARCINOMA OF THE SKIN 4 0.0041
220 TREATMENT FAILURE 331 0.0040
221 POST PROCEDURAL DIARRHOEA 2 0.0039
222 OCCULT BLOOD 2 0.0038
223 LIMB DEFORMITY 6 0.0038
224 CONGENITAL NOSE MALFORMATION 2 0.0038
225 MUSCULOSKELETAL STIFFNESS 329 0.0038
226 INFECTED FISTULA 2 0.0037
227 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 4 0.0037
228 SYNOVIAL CYST 17 0.0037
229 STOMATITIS 222 0.0037
230 RHEUMATOID ARTHRITIS 413 0.0036
231 COLECTOMY TOTAL 2 0.0036
232 LUNG INFECTION PSEUDOMONAL 2 0.0036
233 ANAL FISTULA 19 0.0036
234 NECK PAIN 199 0.0036
235 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 171 0.0036
236 STRESS AT WORK 4 0.0035
237 SWELLING 329 0.0035
238 POUCHITIS 3 0.0035
239 EXPOSURE DURING PREGNANCY 215 0.0035
240 STEROID DEPENDENCE 3 0.0034
241 SLEEP DISORDER 241 0.0034
242 JOINT DISLOCATION 36 0.0034
243 ENTEROCUTANEOUS FISTULA 3 0.0034
244 BLISTER 191 0.0034
245 INJECTION SITE REACTION 234 0.0034
246 MATERNAL EXPOSURE DURING PREGNANCY 302 0.0034
247 GASTROINTESTINAL DISORDER 303 0.0034
248 GASTROOESOPHAGEAL REFLUX DISEASE 271 0.0034
249 ANAL ABSCESS 18 0.0033
250 POLYDIPSIA 13 0.0033
251 ILL-DEFINED DISORDER 198 0.0033
252 JOINT SWELLING 393 0.0033
253 INJURY 228 0.0032
254 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 8 0.0032
255 CEREBELLAR SYNDROME 7 0.0032
256 GENERAL PHYSICAL HEALTH DETERIORATION 368 0.0032
257 PHARYNGEAL PARAESTHESIA 5 0.0031
258 RHEUMATOID LUNG 3 0.0031
259 ANTINUCLEAR ANTIBODY INCREASED 3 0.0031
260 NON-HODGKIN'S LYMPHOMA 4 0.0031
261 DACTYLITIS 3 0.0031
262 PROTEIN TOTAL INCREASED 8 0.0030
263 EXPOSURE TO SARS-COV-2 5 0.0029
264 HAEMOPTYSIS 82 0.0029
265 BLADDER NEOPLASM 5 0.0029
266 AORTITIS 2 0.0029
267 DYSPEPSIA 285 0.0029
268 LYMPHADENITIS 7 0.0029
269 BODY TEMPERATURE FLUCTUATION 6 0.0029
270 INTESTINAL STENOSIS 12 0.0028
271 MITRAL VALVE DISEASE 5 0.0028
272 ILEAL STENOSIS 5 0.0028
273 GASTROINTESTINAL SCARRING 2 0.0028
274 JOINT EFFUSION 19 0.0028
275 FOOD INTOLERANCE 10 0.0027
276 INCORRECT PRODUCT ADMINISTRATION DURATION 59 0.0027
277 BLOOD PARATHYROID HORMONE DECREASED 4 0.0027
278 SCIATICA 43 0.0027
279 PULMONARY TOXICITY 19 0.0027
280 MUSCULOSKELETAL PAIN 140 0.0027
281 ULCER HAEMORRHAGE 18 0.0027
282 DISSEMINATED CRYPTOCOCCOSIS 2 0.0026
283 BRONCHITIS BACTERIAL 2 0.0026
284 DIZZINESS EXERTIONAL 2 0.0026
285 PUSTULAR PSORIASIS 9 0.0026
286 BOWEL MOVEMENT IRREGULARITY 20 0.0026
287 PREMATURE SEPARATION OF PLACENTA 4 0.0026
288 ABDOMINAL DISTENSION 271 0.0026
289 LICHEN PLANUS 6 0.0026
290 SMALL INTESTINAL RESECTION 3 0.0026
291 ADRENOCORTICAL INSUFFICIENCY ACUTE 5 0.0026
292 INFLAMMATORY BOWEL DISEASE 25 0.0026
293 GOUTY ARTHRITIS 2 0.0025
294 GASTROINTESTINAL TOXICITY 12 0.0025
295 ANTIPHOSPHOLIPID SYNDROME 4 0.0025
296 HYPOGLYCAEMIA NEONATAL 4 0.0025
297 BREAST DISORDER 5 0.0024
298 PRESCRIBED OVERDOSE 47 0.0024
299 WALKING AID USER 16 0.0024
300 RECTAL ABSCESS 4 0.0024
301 FISTULA DISCHARGE 3 0.0024
302 HYPOAESTHESIA 352 0.0023
303 ABDOMINAL DISCOMFORT 394 0.0023
304 CROHN'S DISEASE 16 0.0023
305 JOINT STIFFNESS 61 0.0023
306 FUNCTIONAL GASTROINTESTINAL DISORDER 8 0.0023
307 CONDITION AGGRAVATED 702 0.0023
308 FOETAL GROWTH RESTRICTION 14 0.0023
309 ASPERGILLOSIS 3 0.0023
310 ERYTHEMA NODOSUM 8 0.0023
311 DRUG LEVEL DECREASED 23 0.0023
312 NASAL DISORDER 6 0.0023
313 PNEUMOCYSTIS JIROVECI PNEUMONIA 5 0.0022
314 HYPOTHYROIDISM 71 0.0022
315 ALOPECIA 434 0.0022
316 MIGRAINE WITH AURA 6 0.0022
317 SIALOADENITIS 3 0.0022
318 APHTHOUS ULCER 17 0.0022
319 MUSCLE SWELLING 2 0.0022
320 BLOOD PRESSURE DIASTOLIC DECREASED 16 0.0022
321 RESPIRATORY TRACT INFECTION VIRAL 5 0.0021
322 DRY MOUTH 174 0.0021
323 BRONCHIAL OBSTRUCTION 3 0.0021
324 HYPERSENSITIVITY 395 0.0021
325 PLACENTAL DISORDER 2 0.0021
326 OESOPHAGEAL STENOSIS 6 0.0021
327 THERAPEUTIC REACTION TIME DECREASED 6 0.0021
328 MUSCULAR WEAKNESS 233 0.0020
329 MASTOIDITIS 2 0.0020
330 DEFORMITY 19 0.0020
331 COMPLEX REGIONAL PAIN SYNDROME 3 0.0020
332 HYPERAEMIA 4 0.0020
333 TENDERNESS 21 0.0020
334 DRUG ERUPTION 35 0.0020
335 HAEMOGLOBIN INCREASED 9 0.0020
336 BREAST ABSCESS 2 0.0020
337 RUBBER SENSITIVITY 3 0.0020
338 LIPASE INCREASED 15 0.0020
339 FISTULA 22 0.0020
340 BLOOD PRESSURE DIASTOLIC INCREASED 9 0.0019
341 GENOTYPE DRUG RESISTANCE TEST POSITIVE 2 0.0019
342 CONJUNCTIVAL OEDEMA 2 0.0019
343 HYPERTROPHIC CARDIOMYOPATHY 3 0.0019
344 NON-ALCOHOLIC STEATOHEPATITIS 2 0.0019
345 HERNIA REPAIR 5 0.0019
346 COLITIS 73 0.0019
347 FREQUENT BOWEL MOVEMENTS 52 0.0019
348 MIGRAINE 182 0.0019
349 GESTATIONAL DIABETES 9 0.0019
350 AUTOIMMUNE HEPATITIS 13 0.0019
351 MATERNAL EXPOSURE TIMING UNSPECIFIED 7 0.0019
352 POOR VENOUS ACCESS 19 0.0018
353 PILOERECTION 2 0.0018
354 LOWER LIMB FRACTURE 35 0.0018
355 EOSINOPHIL COUNT INCREASED 15 0.0018
356 TONSILLAR HYPERTROPHY 3 0.0018
357 TONGUE ULCERATION 6 0.0018
358 CONFUSIONAL STATE 287 0.0018
359 BLOOD AMYLASE INCREASED 3 0.0018
360 IMMUNE THROMBOCYTOPENIA 8 0.0017
361 HAEMANGIOMA 4 0.0017
362 ACUTE PRERENAL FAILURE 2 0.0017
363 PRESCRIBED UNDERDOSE 34 0.0017
364 INCISION SITE PAIN 2 0.0017
365 IMPAIRED WORK ABILITY 36 0.0017
366 HYPOXIA 59 0.0017
367 ANAPHYLACTIC REACTION 92 0.0017
368 HYPERTENSION 352 0.0017
369 GRANULOMATOSIS WITH POLYANGIITIS 2 0.0017
370 PRODUCTIVE COUGH 79 0.0017
371 EAR INFECTION 44 0.0017
372 PANNICULITIS 4 0.0017
373 SPONDYLITIS 6 0.0016
374 HIP ARTHROPLASTY 25 0.0016
375 BLOOD PRESSURE FLUCTUATION 39 0.0016
376 MUCOUS STOOLS 8 0.0016
377 INTERVERTEBRAL DISC OPERATION 2 0.0016
378 FLANK PAIN 15 0.0016
379 COLITIS ULCERATIVE 70 0.0016
380 BREAST CANCER STAGE II 13 0.0016
381 OESOPHAGEAL ULCER 6 0.0016
382 MYOSITIS 14 0.0016
383 CACHEXIA 8 0.0016
384 ATELECTASIS 15 0.0016
385 RALES 9 0.0015
386 ACTINIC KERATOSIS 4 0.0015
387 DRUG SPECIFIC ANTIBODY PRESENT 10 0.0015
388 WEIGHT INCREASED 341 0.0015
389 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 26 0.0015
390 ULCER 24 0.0015
391 LARGE INTESTINAL STENOSIS 3 0.0015
392 PERIPHERAL SWELLING 231 0.0015
393 DISCOMFORT 90 0.0015
394 PRE-ECLAMPSIA 7 0.0015
395 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 12 0.0015
396 BILIARY TRACT DISORDER 2 0.0014
397 NASOPHARYNGITIS 266 0.0014
398 DEATH NEONATAL 2 0.0014
399 RENAL CELL CARCINOMA 7 0.0014
400 DIVERTICULUM 10 0.0014
401 HEPATIC ENZYME ABNORMAL 7 0.0014
402 LABELLED DRUG-DRUG INTERACTION ISSUE 2 0.0014
403 URTICARIA 230 0.0014
404 UNDERDOSE 100 0.0014
405 PRODUCT USE ISSUE 256 0.0014
406 RHINITIS ALLERGIC 6 0.0013
407 CHOLESTATIC LIVER INJURY 3 0.0013
408 SMALL INTESTINE CARCINOMA 3 0.0013
409 WEIGHT FLUCTUATION 14 0.0013
410 BLOOD LOSS ANAEMIA 3 0.0013
411 PARAESTHESIA 208 0.0013
412 ABNORMAL LOSS OF WEIGHT 9 0.0013
413 ORAL PRURITUS 3 0.0013
414 ARTHRALGIA 540 0.0013
415 MENOPAUSAL SYMPTOMS 3 0.0013
416 JOINT DESTRUCTION 2 0.0013
417 DEFAECATION URGENCY 9 0.0013
418 ASTHMA 143 0.0013
419 ENDOMETRIOSIS 6 0.0013
420 VARICELLA 3 0.0013
421 MEMORY IMPAIRMENT 171 0.0012
422 PROCTALGIA 8 0.0012
423 PAIN IN EXTREMITY 365 0.0012
424 PREMATURE LABOUR 7 0.0012
425 SPINAL FUSION SURGERY 5 0.0012
426 CRYPTOCOCCOSIS 2 0.0012
427 BODY TEMPERATURE DECREASED 12 0.0012
428 DEAFNESS NEUROSENSORY 4 0.0012
429 PEPTIC ULCER 4 0.0012
430 ABSCESS 19 0.0012
431 OSTEITIS 3 0.0012
432 EROSIVE OESOPHAGITIS 2 0.0012
433 ABSCESS LIMB 5 0.0012
434 INCREASED BRONCHIAL SECRETION 3 0.0012
435 HEPATOTOXICITY 26 0.0012
436 PRODUCT USE IN UNAPPROVED INDICATION 287 0.0012
437 HEART RATE IRREGULAR 26 0.0011
438 PAPILLARY THYROID CANCER 2 0.0011
439 APLASTIC ANAEMIA 6 0.0011
440 HYPERSENSITIVITY VASCULITIS 3 0.0011
441 KNEE ARTHROPLASTY 24 0.0011
442 PANCREATITIS 60 0.0011
443 POLYMYOSITIS 2 0.0011
444 GASTROINTESTINAL MOTILITY DISORDER 6 0.0011
445 EPSTEIN-BARR VIRUS INFECTION 7 0.0011
446 PYODERMA GANGRENOSUM 4 0.0011
447 PAPILLOEDEMA 5 0.0011
448 SUSPECTED OFF LABEL USE 5 0.0011
449 MEAN CELL HAEMOGLOBIN DECREASED 2 0.0011
450 UPPER RESPIRATORY TRACT INFECTION 50 0.0011
451 OFF LABEL USE 947 0.0011
452 OSTEOPOROSIS 44 0.0011
453 INSOMNIA 283 0.0011
454 PRODUCT QUALITY ISSUE 144 0.0011
455 SNORING 4 0.0011
456 OXYGEN SATURATION ABNORMAL 3 0.0011
457 ROAD TRAFFIC ACCIDENT 44 0.0011
458 MUSCLE SPASMS 193 0.0011
459 DELIRIUM 36 0.0010
460 RASH VESICULAR 5 0.0010
461 SKIN WARM 6 0.0010
462 OCULAR HYPERTENSION 2 0.0010
463 CUTANEOUS LUPUS ERYTHEMATOSUS 2 0.0010
464 MUSCLE RUPTURE 4 0.0010
465 LYMPHOPROLIFERATIVE DISORDER 3 0.0010
466 PNEUMONIA 330 0.0010
467 SKIN ULCER 26 0.0010
468 ANORECTAL DISORDER 2 0.0010
469 THROMBOSIS 80 0.0010
470 DYSLIPIDAEMIA 5 0.0010
471 CONJUNCTIVITIS 18 0.0010
472 LIVER DISORDER 43 0.0010
473 QUALITY OF LIFE DECREASED 13 0.0010
474 HEART RATE DECREASED 34 0.0010
475 ARTHRITIS 76 0.0010
476 FOETAL DEATH 5 0.0010
477 SKIN NECROSIS 5 0.0010
478 SQUAMOUS CELL CARCINOMA 9 0.0010
479 RECTAL HAEMORRHAGE 41 0.0010
480 HEPATIC NEOPLASM MALIGNANT 2 0.0009
481 MALAISE 414 0.0009
482 HEPATIC CYTOLYSIS 12 0.0009
483 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 169 0.0009
484 ENTERITIS 6 0.0009
485 GENERAL SYMPTOM 7 0.0009
486 RASH 407 0.0009
487 ADVERSE EVENT 86 0.0009
488 DEREALISATION 2 0.0009
489 ABSCESS INTESTINAL 2 0.0009
490 JAW FRACTURE 2 0.0009
491 LEUKOPENIA 46 0.0009
492 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 3 0.0009
493 OTITIS MEDIA 3 0.0009
494 HAEMOLYSIS 7 0.0009
495 INTRACRANIAL PRESSURE INCREASED 5 0.0009
496 HEART RATE ABNORMAL 5 0.0009
497 HEPATOCELLULAR DAMAGE 2 0.0009
498 COLECTOMY 5 0.0009
499 COMPLICATIONS OF TRANSPLANTED KIDNEY 2 0.0009
500 PERONEAL NERVE PALSY 5 0.0009
501 LICHENOID KERATOSIS 2 0.0009
502 TRANSPLANT REJECTION 7 0.0009
503 HAEMATOCHEZIA 48 0.0009
504 THERAPY NON-RESPONDER 39 0.0009
505 DECREASED APPETITE 201 0.0009
506 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
507 HYPERTRANSAMINASAEMIA 6 0.0009
508 ABDOMINAL PAIN UPPER 177 0.0009
509 DISABILITY 17 0.0009
510 BRONCHIOLITIS 3 0.0009
511 PHOTOPHOBIA 16 0.0008
512 RESPIRATORY DISORDER 25 0.0008
513 HEPATIC FUNCTION ABNORMAL 31 0.0008
514 DERMAL CYST 2 0.0008
515 BREATH SOUNDS ABNORMAL 4 0.0008
516 CHOLANGITIS 5 0.0008
517 INFUSION SITE EXTRAVASATION 5 0.0008
518 INJECTION SITE INFLAMMATION 4 0.0008
519 INTESTINAL OBSTRUCTION 30 0.0008
520 ABDOMINAL PAIN LOWER 20 0.0008
521 BRAIN ABSCESS 2 0.0008
522 FEELING JITTERY 15 0.0008
523 DISSEMINATED TUBERCULOSIS 2 0.0008
524 HEPATOSPLENOMEGALY 2 0.0008
525 CONTUSION 75 0.0008
526 DISEASE RECURRENCE 37 0.0008
527 DEPRESSION 176 0.0008
528 FAECES HARD 3 0.0008
529 TONSILLITIS 4 0.0008
530 FALL 255 0.0008
531 RASH MACULO-PAPULAR 17 0.0008
532 PRODUCT PREPARATION ISSUE 5 0.0008
533 SERUM FERRITIN INCREASED 4 0.0008
534 THERAPEUTIC RESPONSE SHORTENED 25 0.0008
535 OBSTRUCTION 3 0.0008
536 DIARRHOEA HAEMORRHAGIC 7 0.0007
537 RHINITIS 6 0.0007
538 INTESTINAL RESECTION 4 0.0007
539 BRONCHIECTASIS 5 0.0007
540 INTERNATIONAL NORMALISED RATIO DECREASED 3 0.0007
541 BACK DISORDER 12 0.0007
542 UVEITIS 10 0.0007
543 ABNORMAL FAECES 6 0.0007
544 HEADACHE 457 0.0007
545 GASTROINTESTINAL PAIN 8 0.0007
546 MACULE 2 0.0007
547 SINUSITIS 73 0.0007
548 SKIN REACTION 10 0.0007
549 LYMPHOPENIA 10 0.0007
550 BASAL CELL CARCINOMA 11 0.0007
551 INTRAOCULAR PRESSURE INCREASED 9 0.0007
552 RETINAL HAEMORRHAGE 5 0.0007
553 VITAMIN D DECREASED 6 0.0007
554 FOETAL EXPOSURE DURING PREGNANCY 57 0.0007
555 OVARIAN CYST 7 0.0007
556 RED BLOOD CELL COUNT DECREASED 20 0.0007
557 FATIGUE 543 0.0007
558 PAIN 428 0.0007
559 FIBULA FRACTURE 2 0.0007
560 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
561 ABDOMINAL PAIN 160 0.0007
562 ABORTION 2 0.0007
563 ADVERSE DRUG REACTION 61 0.0007
564 HISTIOCYTOSIS HAEMATOPHAGIC 2 0.0007
565 WEIGHT DECREASED 188 0.0007
566 EAR PAIN 13 0.0007
567 PREMATURE BABY 20 0.0007
568 PULMONARY EMBOLISM 63 0.0007
569 SQUAMOUS CELL CARCINOMA OF SKIN 4 0.0007
570 PERIPHERAL COLDNESS 9 0.0007
571 PREGNANCY 13 0.0006
572 CONCUSSION 5 0.0006
573 PROTEINURIA 12 0.0006
574 PREMATURE DELIVERY 10 0.0006
575 KIDNEY TRANSPLANT REJECTION 3 0.0006
576 VISUAL IMPAIRMENT 77 0.0006
577 VOMITING 292 0.0006
578 INFUSION SITE PAIN 8 0.0006
579 MOUTH ULCERATION 13 0.0006
580 ANGINA UNSTABLE 4 0.0006
581 SHOCK HAEMORRHAGIC 5 0.0006
582 PLATELET COUNT INCREASED 8 0.0006
583 JOINT INJURY 13 0.0006
584 EYE DISORDER 20 0.0006
585 ASTHENIA 227 0.0006
586 OLIGOHYDRAMNIOS 2 0.0006
587 DYSPNOEA 338 0.0006
588 DIZZINESS 297 0.0006
589 OEDEMA 32 0.0006
590 DRUG INEFFECTIVE 771 0.0006
591 BRONCHOPNEUMONIA 2 0.0006
592 THYROID DISORDER 9 0.0006
593 SKIN LESION 16 0.0006
594 PYELONEPHRITIS 5 0.0006
595 MALABSORPTION 3 0.0006
596 BONE DENSITY DECREASED 18 0.0006
597 EAR PRURITUS 2 0.0006
598 RESPIRATORY TRACT CONGESTION 9 0.0006
599 JAUNDICE CHOLESTATIC 2 0.0006
600 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 31 0.0006
601 GOUT 10 0.0006
602 IMPAIRED QUALITY OF LIFE 8 0.0006
603 PANCYTOPENIA 31 0.0006
604 PHARYNGITIS STREPTOCOCCAL 6 0.0006
605 TIC 3 0.0005
606 CUTANEOUS VASCULITIS 2 0.0005
607 OVERDOSE 118 0.0005
608 ORAL DISORDER 4 0.0005
609 THERAPEUTIC RESPONSE DECREASED 33 0.0005
610 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
611 TOOTH DISORDER 12 0.0005
612 BODY TEMPERATURE INCREASED 11 0.0005
613 NECROSIS 3 0.0005
614 AMNESIA 35 0.0005
615 TOOTH INFECTION 7 0.0005
616 SARS-COV-2 TEST POSITIVE 7 0.0005
617 MOVEMENT DISORDER 17 0.0005
618 NAUSEA 417 0.0005
619 NEPHROLITHIASIS 24 0.0005
620 MATERNAL DRUGS AFFECTING FOETUS 4 0.0005
621 RENAL TUBULAR NECROSIS 5 0.0005
622 BACTERAEMIA 6 0.0005
623 BLOOD ALBUMIN DECREASED 4 0.0005
624 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
625 HYPOMAGNESAEMIA 7 0.0005
626 PROTHROMBIN TIME PROLONGED 3 0.0005
627 BRONCHITIS 37 0.0005
628 INTERSTITIAL LUNG DISEASE 24 0.0005
629 PAIN IN JAW 14 0.0005
630 PYREXIA 171 0.0005
631 NEUTROPHIL COUNT INCREASED 5 0.0005
632 DIARRHOEA 315 0.0005
633 HEPATIC STEATOSIS 9 0.0005
634 RASH PRURITIC 26 0.0005
635 NASAL CONGESTION 28 0.0005
636 HAEMODIALYSIS 4 0.0005
637 OEDEMA PERIPHERAL 58 0.0005
638 THERAPEUTIC RESPONSE CHANGED 3 0.0005
639 INFECTION 68 0.0005
640 COLON CANCER 7 0.0005
641 GASTRIC DISORDER 16 0.0005
642 MUSCULOSKELETAL DISCOMFORT 8 0.0005
643 MULTI-ORGAN FAILURE 8 0.0005
644 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
645 ABDOMINAL ABSCESS 2 0.0005
646 MENINGITIS ASEPTIC 2 0.0004
647 INTESTINAL PERFORATION 5 0.0004
648 FEEDING DISORDER 9 0.0004
649 EYE PAIN 25 0.0004
650 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
651 MYOCARDITIS 5 0.0004
652 LARGE INTESTINE POLYP 3 0.0004
653 EPISTAXIS 32 0.0004
654 ABORTION INDUCED 4 0.0004
655 SEASONAL ALLERGY 6 0.0004
656 CYTOMEGALOVIRUS INFECTION 7 0.0004
657 DRY EYE 21 0.0004
658 CHOLESTASIS 8 0.0004
659 HOSPITALISATION 64 0.0004
660 HYPERTHYROIDISM 6 0.0004
661 GUILLAIN-BARRE SYNDROME 2 0.0004
662 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
663 THROMBOTIC MICROANGIOPATHY 4 0.0004
664 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
665 KIDNEY INFECTION 8 0.0004
666 ANXIETY 116 0.0004
667 HEPATOMEGALY 4 0.0004
668 HYPERCALCAEMIA 5 0.0004
669 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
670 INFLAMMATORY MARKER INCREASED 2 0.0004
671 PHARYNGITIS 5 0.0004
672 CHEST PAIN 74 0.0004
673 BONE LOSS 6 0.0004
674 PERITONITIS BACTERIAL 4 0.0004
675 DRUG TOLERANCE 2 0.0004
676 HYPERTHERMIA 3 0.0004
677 FEELING HOT 24 0.0004
678 WHITE BLOOD CELL COUNT INCREASED 15 0.0004
679 DRUG RESISTANCE 10 0.0004
680 GASTROINTESTINAL INFLAMMATION 3 0.0004
681 AFFECTIVE DISORDER 3 0.0004
682 POLYARTHRITIS 2 0.0004
683 OCULAR HYPERAEMIA 18 0.0004
684 PULMONARY CONGESTION 5 0.0004
685 BLOOD PRESSURE INCREASED 57 0.0004
686 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
687 HEMIPLEGIA 3 0.0004
688 VIRAL INFECTION 12 0.0004
689 PANCREATITIS ACUTE 8 0.0004
690 SWELLING FACE 23 0.0004
691 CHOLECYSTECTOMY 4 0.0003
692 PSEUDOMONAS INFECTION 3 0.0003
693 COVID-19 61 0.0003
694 BLOOD URIC ACID INCREASED 2 0.0003
695 MEDICATION ERROR 19 0.0003
696 SPLENOMEGALY 4 0.0003
697 WHITE BLOOD CELL COUNT DECREASED 37 0.0003
698 LYMPHOCYTE COUNT DECREASED 6 0.0003
699 PURPURA 3 0.0003
700 LABORATORY TEST ABNORMAL 10 0.0003
701 TACHYCARDIA 30 0.0003
702 CHOLELITHIASIS 11 0.0003
703 IMMUNODEFICIENCY 5 0.0003
704 JAUNDICE 9 0.0003
705 ANAL INCONTINENCE 3 0.0003
706 HEPATITIS CHOLESTATIC 2 0.0003
707 PELVIC PAIN 6 0.0003
708 OPTIC NEURITIS 3 0.0003
709 PRURITUS 126 0.0003
710 MUSCLE SPASTICITY 4 0.0003
711 SMALL INTESTINAL OBSTRUCTION 4 0.0003
712 OLIGURIA 2 0.0003
713 BACTERIAL INFECTION 6 0.0003
714 SKIN EXFOLIATION 27 0.0003
715 INFUSION SITE SWELLING 2 0.0003
716 SPUTUM DISCOLOURED 3 0.0003
717 ERECTILE DYSFUNCTION 8 0.0003
718 TREATMENT NONCOMPLIANCE 17 0.0003
719 HERPES SIMPLEX 2 0.0003
720 PSORIASIS 40 0.0003
721 POLYP 2 0.0003
722 ASPERGILLUS INFECTION 2 0.0003
723 HYPOGAMMAGLOBULINAEMIA 2 0.0003
724 SINUS DISORDER 6 0.0003
725 CHOLECYSTITIS CHRONIC 2 0.0003
726 SEPTIC SHOCK 13 0.0003
727 MALIGNANT MELANOMA 4 0.0003
728 BREAST MASS 2 0.0003
729 FACE OEDEMA 5 0.0003
730 METASTASES TO LYMPH NODES 2 0.0003
731 EYE IRRITATION 17 0.0003
732 NEPHROTIC SYNDROME 2 0.0003
733 LIMB DISCOMFORT 9 0.0003
734 PETECHIAE 3 0.0003
735 BLOOD PRESSURE DECREASED 19 0.0003
736 METASTASES TO LIVER 5 0.0003
737 PAPULE 2 0.0003
738 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
739 HAEMOGLOBIN DECREASED 29 0.0003
740 FLATULENCE 16 0.0003
741 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
742 MYELODYSPLASTIC SYNDROME 4 0.0003
743 MENTAL DISORDER 12 0.0003
744 TOOTH FRACTURE 3 0.0003
745 BACK PAIN 63 0.0003
746 HYPERTENSIVE CRISIS 3 0.0003
747 AGRANULOCYTOSIS 5 0.0003
748 HYDRONEPHROSIS 2 0.0003
749 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
750 DERMATITIS CONTACT 3 0.0003
751 GAIT DISTURBANCE 50 0.0003
752 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
753 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
754 CAESAREAN SECTION 3 0.0003
755 ACUTE MYELOID LEUKAEMIA 4 0.0003
756 COVID-19 PNEUMONIA 3 0.0003
757 LOW BIRTH WEIGHT BABY 2 0.0003
758 FEELING COLD 7 0.0003
759 MACULAR DEGENERATION 3 0.0003
760 ADRENAL INSUFFICIENCY 3 0.0002
761 BONE MARROW FAILURE 5 0.0002
762 ERYTHEMA 50 0.0002
763 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
764 NEOPLASM MALIGNANT 16 0.0002
765 COUGH 67 0.0002
766 BLOOD UREA INCREASED 4 0.0002
767 BRAIN OEDEMA 3 0.0002
768 DRUG EXPOSURE DURING PREGNANCY 8 0.0002
769 ROTATOR CUFF SYNDROME 3 0.0002
770 BLOOD MAGNESIUM DECREASED 2 0.0002
771 MYOPATHY 2 0.0002
772 NEUROPATHY PERIPHERAL 22 0.0002
773 ECZEMA 12 0.0002
774 NEUTROPENIA 31 0.0002
775 IMMUNOSUPPRESSION 2 0.0002
776 UNEVALUABLE EVENT 17 0.0002
777 MYALGIA 38 0.0002
778 HEAVY MENSTRUAL BLEEDING 2 0.0002
779 HIDRADENITIS 2 0.0002
780 OROPHARYNGEAL PAIN 20 0.0002
781 BREAST CANCER STAGE I 2 0.0002
782 INFLUENZA 24 0.0002
783 APPENDICITIS 2 0.0002
784 FEELING ABNORMAL 51 0.0002
785 LIP SWELLING 7 0.0002
786 ANGINA PECTORIS 6 0.0002
787 INCREASED APPETITE 4 0.0002
788 DEPRESSED MOOD 11 0.0002
789 GLAUCOMA 4 0.0002
790 HERNIA 4 0.0002
791 LOCALISED INFECTION 5 0.0002
792 GASTROENTERITIS 3 0.0002
793 HAEMORRHOIDS 4 0.0002
794 CEREBRAL INFARCTION 5 0.0002
795 ANGIOEDEMA 9 0.0002
796 HAEMORRHAGE 21 0.0002
797 ABORTION SPONTANEOUS 8 0.0002
798 CELLULITIS 10 0.0002
799 LYMPHADENOPATHY 7 0.0002
800 SEPSIS 22 0.0002
801 DRY THROAT 2 0.0002
802 FLUID RETENTION 10 0.0002
803 CHEST DISCOMFORT 20 0.0002
804 HYPOKALAEMIA 9 0.0002
805 DEVICE RELATED INFECTION 3 0.0002
806 EAR DISCOMFORT 2 0.0002
807 DEAFNESS 5 0.0002
808 INCONTINENCE 2 0.0002
809 CYSTITIS 6 0.0002
810 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
811 RHINORRHOEA 12 0.0002
812 MUSCLE TIGHTNESS 3 0.0002
813 THROAT TIGHTNESS 5 0.0002
814 CATARACT 11 0.0002
815 PRODUCT PRESCRIBING ISSUE 4 0.0002
816 ASPIRATION 2 0.0002
817 DRUG LEVEL INCREASED 3 0.0002
818 RESPIRATORY DISTRESS 5 0.0002
819 TRANSAMINASES INCREASED 4 0.0002
820 MALNUTRITION 2 0.0002
821 OCULAR DISCOMFORT 2 0.0002
822 OXYGEN SATURATION DECREASED 10 0.0002
823 CIRCULATORY COLLAPSE 3 0.0002
824 MYOCARDIAL ISCHAEMIA 2 0.0002
825 HERPES ZOSTER 10 0.0002
826 ELECTROLYTE IMBALANCE 2 0.0002
827 EYELID OEDEMA 2 0.0002
828 HEART RATE INCREASED 17 0.0002
829 CHILLS 20 0.0002
830 ASCITES 5 0.0002
831 THROMBOCYTOPENIA 19 0.0002
832 HYPOTENSION 34 0.0002
833 GALLBLADDER DISORDER 3 0.0002
834 CHOLECYSTITIS 2 0.0002
835 POLYNEUROPATHY 2 0.0002
836 GASTROENTERITIS VIRAL 3 0.0002
837 OSTEOMYELITIS 3 0.0002
838 CORONARY ARTERY DISEASE 5 0.0002
839 RENAL FAILURE ACUTE 7 0.0002
840 PRESYNCOPE 4 0.0002
841 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
842 CYST 2 0.0002
843 ILEUS 2 0.0002
844 DERMATITIS ALLERGIC 2 0.0002
845 URINARY TRACT INFECTION 27 0.0002
846 INFLUENZA LIKE ILLNESS 13 0.0002
847 MUSCLE ATROPHY 2 0.0002
848 THROAT IRRITATION 7 0.0002
849 ILLNESS 16 0.0002
850 ANOREXIA 2 0.0002
851 RESPIRATORY TRACT INFECTION 4 0.0002
852 SURGERY 9 0.0002
853 ORAL CANDIDIASIS 2 0.0002
854 IMMUNE SYSTEM DISORDER 2 0.0002
855 HAEMATOCRIT DECREASED 3 0.0002
856 INCORRECT DOSE ADMINISTERED 34 0.0001
857 DRUG TOXICITY 2 0.0001
858 PERITONITIS 3 0.0001
859 TOOTH LOSS 3 0.0001
860 HUNGER 2 0.0001
861 MASS 2 0.0001
862 RASH MACULAR 5 0.0001
863 CARPAL TUNNEL SYNDROME 2 0.0001
864 DEVICE OCCLUSION 2 0.0001
865 HEPATOCELLULAR INJURY 2 0.0001
866 LIVER FUNCTION TEST ABNORMAL 4 0.0001
867 APATHY 2 0.0001
868 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
869 CARDIOMYOPATHY 2 0.0001
870 STEVENS-JOHNSON SYNDROME 3 0.0001
871 HYPOAESTHESIA ORAL 2 0.0001
872 DRUG INTERACTION 21 0.0001
873 BLOOD COUNT ABNORMAL 2 0.0001
874 VERTIGO 8 0.0001
875 DIABETES MELLITUS 10 0.0001
876 DRUG DEPENDENCE 21 0.0001
877 SHOCK 3 0.0001
878 BREAST CANCER 12 0.0001
879 NERVOUS SYSTEM DISORDER 4 0.0001
880 PLASMA CELL MYELOMA 5 0.0001
881 DIABETIC KETOACIDOSIS 3 0.0001
882 ACUTE KIDNEY INJURY 19 0.0001
883 BLOOD POTASSIUM INCREASED 2 0.0001
884 BLINDNESS 5 0.0001
885 BLOOD CREATININE INCREASED 8 0.0001
886 RHABDOMYOLYSIS 5 0.0001
887 PRODUCT COMPLAINT 3 0.0001
888 HEMIPARESIS 2 0.0001
889 HAEMATURIA 4 0.0001
890 ANAPHYLACTIC SHOCK 3 0.0001
891 HYPERKALAEMIA 4 0.0001
892 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
893 DEHYDRATION 15 0.0001
894 DISTURBANCE IN ATTENTION 6 0.0001
895 ANAEMIA 21 0.0001
896 MOOD ALTERED 3 0.0001
897 BONE DISORDER 2 0.0001
898 DYSURIA 4 0.0001
899 DYSPNOEA EXERTIONAL 4 0.0001
900 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
901 RENAL FAILURE 14 0.0001
902 BALANCE DISORDER 9 0.0001
903 ACUTE RESPIRATORY FAILURE 2 0.0001
904 ATRIAL FIBRILLATION 10 0.0001
905 ORAL HERPES 2 0.0001
906 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
907 BLOOD PRESSURE ABNORMAL 2 0.0001
908 PLEURAL EFFUSION 6 0.0001
909 NEUTROPHIL COUNT DECREASED 4 0.0001
910 CONSTIPATION 21 0.0001
911 CARDIAC DISORDER 9 0.0001
912 DERMATITIS 2 0.0001
913 METABOLIC ACIDOSIS 3 0.0001
914 HIP FRACTURE 3 0.0001
915 ACNE 7 0.0001
916 OSTEONECROSIS 3 0.0001
917 STAPHYLOCOCCAL INFECTION 3 0.0001
918 MELAENA 2 0.0001
919 SKIN DISORDER 3 0.0001
920 EYE PRURITUS 3 0.0001
921 HYPONATRAEMIA 5 0.0001
922 TINNITUS 4 0.0001
923 LETHARGY 5 0.0001
924 PERICARDIAL EFFUSION 2 0.0001
925 NEOPLASM PROGRESSION 3 0.0001
926 HYPERHIDROSIS 11 0.0001
927 COMA 4 0.0001
928 DEATH 71 0.0001
929 PRODUCT DOSE OMISSION ISSUE 24 0.0001
930 AGEUSIA 2 0.0001
931 HAEMATEMESIS 2 0.0001
932 FLUSHING 8 0.0001
933 HAEMATOMA 2 0.0001
934 NERVOUSNESS 4 0.0001
935 DISEASE PROGRESSION 9 0.0001
936 GASTRITIS 2 0.0001
937 MENSTRUATION IRREGULAR 2 0.0001
938 FEAR 2 0.0001
939 LIMB INJURY 2 0.0001
940 PALLOR 2 0.0001
941 DIVERTICULITIS 2 0.0001
942 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
943 HYPERSOMNIA 2 0.0001
944 SOMNOLENCE 14 0.0001
945 NEEDLE ISSUE 2 0.0001
946 PALPITATIONS 8 0.0001
947 BLOOD POTASSIUM DECREASED 2 0.0001
948 EMOTIONAL DISTRESS 8 0.0001
949 PLATELET COUNT DECREASED 7 0.0001
950 EMOTIONAL DISORDER 2 0.0001
951 RENAL DISORDER 3 0.0001
952 ARRHYTHMIA 3 0.0001
953 DYSPHAGIA 6 0.0001
954 HEAD INJURY 2 0.0001
955 MYOCARDIAL INFARCTION 11 0.0001
956 LOSS OF CONSCIOUSNESS 8 0.0001
957 HYPOGLYCAEMIA 3 0.0001
958 DRY SKIN 8 0.0001
959 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
960 SPEECH DISORDER 3 0.0001
961 INTENTIONAL PRODUCT MISUSE 5 0.0001
962 BURNING SENSATION 4 0.0001
963 DRUG EFFECT INCOMPLETE 2 0.0001
964 RESPIRATORY FAILURE 4 0.0001
965 AGITATION 4 0.0001
966 EYE SWELLING 2 0.0001
967 TOXICITY TO VARIOUS AGENTS 9 0.0001
968 DYSARTHRIA 2 0.0001
969 CARDIAC FAILURE 4 0.0000
970 CARDIAC ARREST 4 0.0000
971 INJECTION SITE ERYTHEMA 6 0.0000
972 TREMOR 8 0.0000
973 HYPOACUSIS 2 0.0000
974 DEEP VEIN THROMBOSIS 3 0.0000
975 VISION BLURRED 6 0.0000
976 MULTIPLE SCLEROSIS 2 0.0000
977 SYNCOPE 4 0.0000
978 INJECTION SITE SWELLING 3 0.0000
979 DERMATITIS ATOPIC 2 0.0000
980 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
981 DYSPHONIA 2 0.0000
982 NO ADVERSE EVENT 6 0.0000
983 INTENTIONAL OVERDOSE 2 0.0000
984 CEREBROVASCULAR ACCIDENT 5 0.0000
985 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
986 HOT FLUSH 2 0.0000
987 SEIZURE 3 0.0000
988 INJECTION SITE BRUISING 2 0.0000
989 CARDIAC FAILURE CONGESTIVE 2 0.0000
990 INJECTION SITE PAIN 7 0.0000
991 DRUG DOSE OMISSION 2 0.0000
992 BLOOD GLUCOSE INCREASED 2 0.0000